Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/30977
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHong, Jason T-
dc.contributor.authorJames, Simon-
dc.contributor.authorTran, Anthony-
dc.contributor.authorKutaiba, Numan-
dc.date2022-
dc.date.accessioned2022-10-07T05:29:57Z-
dc.date.available2022-10-07T05:29:57Z-
dc.date.issued2022-09-25-
dc.identifier.citationANZ Journal of Surgery 2022; 92(12)en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/30977-
dc.description.abstractPatients with Crohn's disease (CD) have a high likelihood of being sarcopenic. Several studies have shown a positive correlation between sarcopenia measured as skeletal muscle index (SMI) and poor surgical outcomes in patients with CD. Our primary aim was to correlate SMI with the psoas muscle index (PMI), an easier measurement of sarcopenia. Secondary aim was to correlate SMI and PMI with clinical outcomes in a cohort of CD patients requiring surgery. A retrospective cohort study of CD patients who underwent surgery at a public health service from January 2010 to December 2019. Using computed tomography and magnetic resonance enterography studies, skeletal muscle area was measured at the third lumbar vertebra level. SMI and PMI were calculated and correlated. Correlation between SMI and PMI with surgical outcomes was performed. Seventy-six patients were included. Median length of stay (LOS) was 6 days (IQR, 5 to 9). Eleven patients (14.5%) required ICU admission, nine patients (11.8%) required TPN and thirteen patients (17.1%) had complications. The prevalence of sarcopenia was 63.2% based on the SMI threshold of 52.4 and 38.5 cm2 /m2 for men and women, respectively. A positive correlation between SMI and PMI was found (r = 0.72, P < 0.0001). Sarcopenia status based on reported thresholds for SMI and for PMI showed no significant correlation with outcomes (LOS, ICU admission and complications). SMI and PMI show good correlation but there is insufficient evidence to suggest that sarcopenia status using either measurement has a significant impact on predicting clinical outcomes.en
dc.language.isoeng-
dc.subjectCrohn's diseaseen
dc.subjectinflammatory bowel diseaseen
dc.subjectpsoas muscle indexen
dc.subjectsarcopeniaen
dc.subjectskeletal muscle indexen
dc.subjectsurgical outcomesen
dc.titleSarcopenia measurements and clinical outcomes in Crohn's disease surgical patients.en
dc.typeJournal Articleen
dc.identifier.journaltitleANZ journal of surgeryen
dc.identifier.affiliationRadiologyen
dc.identifier.affiliationSchool of Information Technology, Deakin University, Geelong, Victoria, Australiaen
dc.identifier.affiliationFaculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Victoria, Australiaen
dc.identifier.affiliationDepartment of Radiology (Imaging Associates), Box Hill Hospital, Box Hill, Victoria, Australiaen
dc.identifier.affiliationDepartment of Colorectal Surgery, Box Hill Hospital, Box Hill, Victoria, Australiaen
dc.identifier.doi10.1111/ans.18063en
dc.type.contentTexten
dc.identifier.orcid0000-0002-0514-3532en
dc.identifier.pubmedid36156838-
local.name.researcherKutaiba, Numan
item.grantfulltextnone-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
crisitem.author.deptRadiology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

28
checked on Dec 12, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.